This inventor holds 1 USPTO granted patent. Top assignee: American Home Products Corporation. Active years: 1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987
Title: Michael Kraml: Innovator in Aldose Reductase Inhibitors
Introduction
Michael Kraml is a notable inventor based in Princeton Junction, NJ (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of aldose reductase inhibitors. His work is aimed at addressing diabetic complications, showcasing his commitment to improving healthcare outcomes.
Latest Patents
Kraml holds a patent for a compound identified as N[[5-(trifluoromethyl)-6-methoxy-1-naphthalenyl]-thioxomethyl]-N. This patent discloses tolrestat amides and methods of preparation. The amides developed by Kraml are recognized for their potential use in the treatment or prevention of complications arising from diabetes.
Career Highlights
Throughout his career, Kraml has been associated with American Home Products Corporation, where he has contributed to various innovative projects. His expertise in medicinal chemistry has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Kraml has worked alongside esteemed colleagues such as Francesco Bellini and Kazimir Sestanj. Their collaborative efforts have further advanced the research and development of new therapeutic agents.
Conclusion
Michael Kraml's innovative work in the field of aldose reductase inhibitors highlights his dedication to addressing critical health issues. His contributions continue to influence the pharmaceutical landscape, making a positive impact on the treatment of diabetes-related complications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile